Reduced numbers of regulatory T cells in breast carcinoma with medullary features

Histopathology

Volumn 59, Issue 2, 2011, Pages 345-349

  Vong, Joaquim S ^a   Yu, Alex M C ^a   Ng, David C H ^a   Lui, Philip C W ^a   Law, Bonita K B ^b   Chau, Helen H L ^a   Tan, Puay Hoon ^c   Tse, Gary M ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b Union Hospital   (Hong Kong)

^c SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

ANTIGEN EXPRESSION; BREAST CARCINOMA; CANCER SURVIVAL; EFFECTOR CELL; ILLNESS TRAJECTORY; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; LETTER; LYMPHOCYTIC INFILTRATION; MEDULLARY CARCINOMA; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE;

ADULT; AGED; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, MEDULLARY; CELL COUNT; FEMALE; HUMANS; MIDDLE AGED; NEOPLASMS, MULTIPLE PRIMARY; T-LYMPHOCYTES, REGULATORY; TUMOR MARKERS, BIOLOGICAL;

EID: 80052237205     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2011.03903.x     Document Type: Letter

References (7)

1. Yu P, Fu YX. Tumor-infiltrating T lymphocytes: friends or foes? Lab. Invest. 2006; 86; 231-245.
2. Guo X, Fan Y, Lang R et al. Tumor infiltrating lymphocytes differ in invasive micropapillary carcinoma and medullary carcinoma of breast. Mod. Pathol. 2008; 21; 1101-1107.
3. Kuroda H, Tamaru J, Sakamoto G, Ohnisi K, Itoyama S. Immunophenotype of lymphocytic infiltration in medullary carcinoma of the breast. Virchows Arch. 2005; 446; 10-14.
4. Vincent-Salomon A, Gruel N, Lucchesi C et al. Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res. 2007; 9; R24.
5. Bertucci F, Finetti P, Cervera N et al. Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers. Cancer Res. 2006; 66; 4636-4644.
6. Bohling SD, Allison KH. Immunosuppressive regulatory T cells are associated with aggressive breast cancer phenotypes: a potential therapeutic target. Mod. Pathol. 2008; 21; 1527-1532.
7. Shen Z, Zhou S, Wang Y et al. Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J. Cancer Res. Clin. Oncol. 2010; 136; 1585-1595.